Digestive HealthNCT06946017
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
A study testing Fermented dairy protein with prebiotic fiber supplement in people with Digestive Health and Quality of Life, run by Arizona State University at 1 site in United States.
Trial summary
A positive impact of a fermented dairy protein with prebiotic fiber supplement on self-reported GI complaints and wellbeing has been suggested (Wardenaar et al. 2024). The following project aims to further investigate the impact of this supplements in athletes with and without GI complaints in two separate data… Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Digestive Health, Quality of Life
- What is being tested?
- Fermented dairy protein with prebiotic fiber supplement
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 114 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Mar 2025to 30 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy subjects living in the Phoenix area in AZ, USA during the study
- Women/Men aged between 18-50 years (50-50%)
- Recreational competitive and non-competitive athletes (exercise at least 2x per week with a minimal total duration of 2 hours/week)
- BMI value between ≥18.5 and ≤ 30 kg/m2
- No physical limitations due to an injury (i.e., able to perform all activities associated with daily living and exercise in an independent manner).
- Willing to slightly increase their energy intake via a supplement during the study period on daily basis in the morning before breakfast.
Show all 11Show fewer
- Willing and comfortable to perform multiple physical (stress) tests on a treadmill during the study.
- Participants without any contraindications when scoring the Physical Activity Readiness Questionnaire (PAR-Q+).
- Written informed consent
- For part I: Self-perceived lactose intolerance, and/or omission of dairy products, and/or identifying as Hispanic/Latino or Asian
- For part I: Determined to be lactase non-persistent (LNP) CC genotype by qPCR, and/or positive lactose intolerance test (>20ppm increase from baseline when 25g of lactose administered)
Who cannot join
- Users of (sport) supplements containing probiotics and/or prebiotics and those unwilling to temporarily stop use of these supplements at least 3 weeks prior to start of the intervention
- Women who plan to start or stop the use of contraceptives before or during study period
- Women that have additional or worse GI symptoms during their period that can be classified as severe
- Smoking
- Clinical lactose intolerance
- Clinical or self-perceived milk protein allergy
Show all 18Show fewer
- Diagnosed GI tract disorders or diseases
- Musculoskeletal disorders
- Diagnosed metabolic disorders (such as diabetes)
- Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
- Chronic use of gastric acid suppressing medication or anti-coagulants
- Chronic use of anti-inflammatory medication
- Use of antibiotics the past 0-6 months
- Blood donation in the past 2 months
- (Intending to become) Pregnant/lactating women
- Significant changes in body weight during the past 4 weeks (i.e., due to reduction of body weight through limiting caloric intake, illness,)
- Athletes should not aim to lose bodyweight by reducing energy intake during the study
- For Part I: A hydrogen breath peak of less than 20 ppm over baseline during a lactose tolerance test
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Kinta Schott, MS contact
United States1 site, 1 recruiting
- Recruiting
ASU Health Futures Center
Phoenix, Arizona, 85054
Kinta Schott, MS, 602-543-1853, kschott3@asu.edu
About this study
Official title: Effect of a Fermented Whey and Fiber Supplement on Digestive Comfort of Recreational Athletes With and Without GI Complaints
A positive impact of a fermented dairy protein with prebiotic fiber supplement on self-reported GI complaints and wellbeing has been suggested (Wardenaar et al. 2024). The following project aims to further investigate the impact of this supplements in athletes with and without GI complaints in two separate data collections.
Part I of the data collection aims to investigate the impact of this supplement vs. a placebo on carbohydrate malabsorption (as a potential cause for GI distress) in athletes that normally don't identify as having GI complaints (randomized double-blind cross over study design covering a total of 9 weeks, including a 3-week washout period).
Part II of the data collection aims to confirm the earlier found results in the previous study (Wardenaar et al. 2024) in a group athletes self-reporting GI complaints that will be randomized into an intervention group or a placebo group (randomized double-blind parallel study design covering a total of 3 weeks).
Read the detailed description
A substantial number of athletes suffer from gastro-intestinal (GI) problems, which may impair performance and/or subsequent recovery. Regardless of the prevalence of GI complaints, gut barrier integrity is impaired with high-intensity training. Emerging studies show a positive correlation between the gut microbiome and GI problems and general health and wellbeing.
This project will perform two well-controlled studies:
Part I will be looking into the impact of a 3-week supplementation of fermented dairy protein with prebiotic fiber supplement vs. 3-week supplementation of a control supplement on carbohydrate malabsorption (by means of a lactose tolerance test), Bifidobacterium, GI complaints, general well-being and overall gut microbiota in people screened for not reporting substantial GI complaints while being lactose non-persistent (LNP) and/or being responsive to a lactose tolerance test.
Part II investigates the impact of a 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement vs. a control supplement on GI complaints, Bifidobacterium, general well-being, overall gut microbiota, immune markers, gut redox status, and short chain fatty acids in feces in people screened for reporting substantial GI complaints.
Both study parts include multiple standardized exercise tests before and after each supplementation period (Part I: 4 exercise testing days, Part II: 2 exercise testing days). The participants will come in fasted (after not eating starting 10 pm the night before) and they will perform a 60-minute hiking protocol in a warm environment. After the first-time participants will copy their personal exercise protocol during the following session(s). The exercise exists of hiking on a treadmill in a warm environment (30-35°C), while reaching an exercise intensity of 70% of the subject's VO2 max. Which is an intensity in which the subject has an elevated breathing frequency but is still able to talk.
SCREENING After being eligible on paper (based on the results of an online screening questionnaire) people are invited to sign informed consent via REDCap, a secure, web-based application designed for building and managing online surveys and databases for research studies.
For Part I an addition screening step is included to determine eligibility, including a buccal swab to determine lactose non-persistence (to identify the CC gene), as well as a lactose tolerance test (administration of a dose of 25g of lactose mixed into 250mL, with hydrogen breath measurements at 30-, 60- and 90-minutes after lactose consumption). For Part II no additional screening will be performed.
FAMILIARIZATION VISIT Before performing any exercise, body height and weight, as well as waist and hip circumference will be taken by a research team member, and some additional questions will be asked about exercise and diet habits. After this the participant will perform a maximal exercise test, that will be used to determine the exercise intensity during the following exercise sessions. For this purpose, the Balke protocol will be used and VO2 max will be measured. This test includes a treadmill walking/hiking test including progressive stages where the incline increases each minute (by 1%), but the speed remains 3.3mph.
EXERCISE TEST (PART I and PART II) The treadmill will start at 70% of the final incline determined by the max test and participants will start the speed determined by the familiarization test and will be increased as necessary to achieve a heart rate associated with 70% of the VO2max measured during the familiarization visit using a Balke test. Heart rate and speed will be continuously monitored, when speed needs to be adjusted at a later phase during the protocol (because heart rate is not within the targeted HR-range), this will be registered to allow for exact copying the protocol during the next exercise sessions. The exercise will consist of 60 minutes of steady-state exercise. A rating of perceived exertion (RPE) measure via a BORG visual analog scale will be taken every 10-minutes to ensure participants are maintaining a moderate level activity. Only during Part I participants will receive a feeding after the exercise test. Participants will receive at the end of the exercise test 25g lactose mixed into 250mL water, no food will be provided after the heat stress test, but water can be consumed ad libitum.
PART I This part has a randomized controlled cross-over design: Some of the data collection will take place at home (e.g the collection of stool samples, 1-3 minutes per sample, 4-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 4-12 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.
Measurements for different testing days for Part I:
Day ≤0: Screening questionnaire (allowing to select eligible athletes based on the criteria listed in inclusion and exclusion criteria). Sign informed consent, perform exercise test to determine heart rate submax including measuring body composition. Provide instructions and provide stool sample collection materials.
Test Day 0, 21, 42, 63: Fecal swab (for microbiota-redox activity) before arrival; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires at arrival. Blood sample is taken based on a finger prick using a lancet method (for SCFA/LBP) before the exercise test followed by the exercise test, and another finger prick (~150 uL blood for LBP). After the lactose dose is consumed post-exercise, multiple hydrogen breath samples are collected (malabsorption). Hydrogen measurements will be issued at baseline (-60 min), post-exercise (0 min), 30-minutes post-exercise (30 min), 60-minutes post-exercise (60 min), 90-minutes post-exercise (90min), 120-minutes post-exercise (120min) 150-minutes post-exercise (150min), 180-minutes post-exercise (180min), 210-minutes post exercise and 240-minutes post exercise (240min). Hydrogen breath analysis is a minimally invasive procedure which requires the participant to breath normally but exhale into a gas sample bag until the 250mL bag is filled. Prior to taking a hydrogen breath sample, a 10mL mouthwash rinse followed by a rinse with water to prevent bacterial flora from affecting the hydrogen breath measures will be completed before each measure of hydrogen.
Accompanying the hydrogen breath test at 0 min, 60 min, 120 min, 180 min and 240 min, an adjusted GSRS questionnaire will also be given for self-reported digestive comfort during the last 60 minutes.
Test Day 0+1; Day 21+1, Day 42+1, Day 63+1: Before the exercise stress test the regular GSRS will be provided to reflect self-reported digestive comfort during the last week, and a 24-hour after exercise an adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.
Research questions for Part I:
Question 1: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers lactose malabsorption reflected by consecutive hydrogen breath measurements compared to a control after 60-minute hiking exercise in the heat.
Question 2: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.
Question 3: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) during the lactose tolerance test after 60-minute hiking exercise in the heat.
Question 4: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota.
PART II This part has a randomized controlled parallel design: Some of the data collection will take place at home (e.g the collection of stool samples, 3-6 minutes for two samples a time, 6-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 2-6 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.
Measurements for different testing days for Part II:
Screening (Day ≤0): Screening questionnaire (select eligible athletes based on inclusion and exclusion criteria); Sign informed consent, perform exercise test to determine heart rate submax, including measuring body composition. Provide instructions and provide stool sample collection materials.
Baseline (Day 0) and Endpoint (Day 21): Fecal swab (for microbiota-redox activity, SFCA composition) before arrival; Venous blood sample (5 mL to measure TNF-a, CRP, IL-4, IL-6, IL-8, IL-10, MCP-1) and saliva (check swab to measure sIgA, and assessment of flow rate) collection for immune markers; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires filled out online. An additional blood sample is taken based on a finger prick using a lancet method (~250 uL blood to measure SCFA and LBP) before the exercise test followed by the exercise test, and another finger prick (to measure LBP again).
Day 0+1 and Day 21+1: day after exercise stress test: A 24-hour after exercise adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.
Research questions for Part II:
Question 5: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) before, directly after, and 24-hours after 60-minute hiking exercise in the heat compared to a control.
Question 6: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.
Question 7: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota compared to a control.
Question 8: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in immune markers, gut redox status and fecal short chain fatty acids compared to a control.
- Conditions
- Digestive Health, Quality of Life
- Being tested
- Fermented dairy protein with prebiotic fiber supplement, Control placebo
- Keywords
- Participants, Healthy subjects, Athlete, Women, Men, Fermented Dairy, Prebiotics, Gut microbiota, Self-reported, GI-tract, Diet, Immune markers, Exercise
- Medical subject headings
- Multiple Endocrine Neoplasia Type 1, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fermented dairy protein with prebiotic fiber supplementDietary supplement
Both the intervention and placebo products contain a serving of 15g with ~53Kcal, 0.5g Fats, 5g Carbohydrate, 7.5g Protein that need to be dissolved as powder in water in a protein shaker that will be provided. The intervention product contains whey protein concentrate and a prebiotic fiber. All ingredients that are designated by the FDA as Generally Recognized as Safe (GRAS). Participants will be asked to take the supplement daily before breakfast.
Control placeboDietary supplement
Both the intervention and placebo products contain a serving of 15g with ~53Kcal, 0.5g Fats, 5g Carbohydrate, 7.5g Protein that need to be dissolved as powder in water in a protein shaker that will be provided. The placebo product is calorically matched to the intervention product and the main ingredients are protein and carbohydrate. All ingredients that are designated by the FDA as Generally Recognized as Safe (GRAS). Participants will be asked to take the supplement daily before breakfast.
| Study group | Role | What they receive |
|---|---|---|
| Fermented dairy protein with prebiotic fiber | Experimental | During 3-week period participants consume a fermented dairy protein with prebiotic fiber.
During Part I participants are randomly assigned to start with the experimental arm or the control arm, after a 3-week washout period, they will supplement again for 3 weeks with the opposite supplement (double blind, randomized cross-over trial).
During Part II participants are randomly assigned to the experimental arm only (double blind, randomized parallel trial). Receives: Dietary Supplement: Fermented dairy protein with prebiotic fiber supplement |
| Control protein supplement | Placebo comparator | During 3-week period participants consume a control supplement.
During Part I participants are randomly assigned to start with the control arm or the experimental arm, after a 3-week washout period, they will supplement again for 3 weeks with the opposite supplement (double blind, randomized cross-over trial).
During Part II participants are randomly assigned to the control arm only (double blind, randomized parallel trial). Receives: Dietary Supplement: Control placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Part I: Hydrogen in breath
Hydrogen in breath as indicator of lactose malabsorption.
Measured: For 240 minutes post exercise after consuming a bolus of lactose.
Part II: Gastrointestinal Symptoms Rating Scores
Gastrointestinal Symptoms Rating Scores (GSRS) as indicator of self-reported digestive comfort. The GSRS is a 15-item self-administered questionnaire divided into five clusters of symptoms: reflux, abdominal pain, indigestion, diarrhea, and constipation. These symptoms are graded on a 7-point Likert scale, where 1 signifies no discomfort at all and 7 represents very severe discomfort. The total score will be calculated, as well as the percentage of subjects reporting symptoms (≥2), or moderate to severe symptoms (≥4). A minimal score of indicates no GI symptoms, whereas a score up to 105 suggests extreme GI symptoms.
Measured: For 240 minutes post exercise after consuming a bolus of lactose.
Secondary outcomes (1)
Part I and Part II: Fecal Bifidobacterium
Fecal Bifidobacterium as a (partial) mechanistic explanation for a change in carbohydrate (lactose) absorption or self-reported digestive comfort.
Measured: Stool sample collected at least one day before the test day including the exercise test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Apr 2025
- Study start31 Mar 2025
- Primary completion20 Sep 2026
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Digestive HealthStudies of the same condition, open and under way.
- More trials run by Arizona State UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Part I is a crossover design. Part II is a parallel design.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 114 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Arizona State University
- Sponsor type
- University, hospital or other
- Collaborators
- FrieslandCampina N.V.
- Responsible party
- Principal investigator, Floris Wardenaar, Arizona State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06946017
- Sponsor's protocol ID
- STUDY00020575
- Status last verified
- Oct 2026
- First submitted
- 17 Apr 2025
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: This is up to the industry funder to allow sharing.
Publications
Wardenaar FC, Mohr AE, Ortega-Santos CP, Nyakayiru J, Kersch-Counet C, Chan Y, Clear AM, Kurka J, Schott KD, Seltzer RGN. Explorative Characterization of GI Complaints, General Physical and Mental Wellbeing, and Gut Microbiota in Trained Recreative and Competitive Athletes with or without Self-Reported Gastrointestinal Symptoms. Nutrients. 2024 May 30;16(11):1712. doi: 10.3390/nu16111712.
PubMed 38892645
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of a Fermented Whey and Fiber Supplement on Digestive Comfort of Recreational Athletes With and Without GI Complaints
- ClinicalTrials.gov ID
- NCT06946017
- Acronym / sponsor ID
- STUDY00020575
- Conditions
- Digestive Health, Quality of Life
- Keywords
- Participants, Healthy subjects, Athlete, Women, Men, Fermented Dairy, Prebiotics, Gut microbiota
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 114 participants (estimated)
- Lead sponsor
- Arizona State UniversityUniversity, hospital or other
- Collaborators
- FrieslandCampina N.V.
- Study start
- 31 Mar 2025 (actual)
- Primary completion
- 20 Sep 2026 (actual)
- Study completion
- 30 Jun 2027 (estimated)
- First posted
- 27 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A positive impact of a fermented dairy protein with prebiotic fiber supplement on self-reported GI complaints and wellbeing has been suggested (Wardenaar et al. 2024). The following project aims to further investigate the impact of this supplements in athletes with and without GI complaints in two separate data collections.
Part I of the data collection aims to investigate the impact of this supplement vs. a placebo on carbohydrate malabsorption (as a potential cause for GI distress) in athletes that normally don't identify as having GI complaints (randomized double-blind cross over study design covering a total of 9 weeks, including a 3-week washout period).
Part II of the data collection aims to confirm the earlier found results in the previous study (Wardenaar et al. 2024) in a group athletes self-reporting GI complaints that will be randomized into an intervention group or a placebo group (randomized double-blind parallel study design covering a total of 3 weeks).
Detailed description
A substantial number of athletes suffer from gastro-intestinal (GI) problems, which may impair performance and/or subsequent recovery. Regardless of the prevalence of GI complaints, gut barrier integrity is impaired with high-intensity training. Emerging studies show a positive correlation between the gut microbiome and GI problems and general health and wellbeing.
This project will perform two well-controlled studies:
Part I will be looking into the impact of a 3-week supplementation of fermented dairy protein with prebiotic fiber supplement vs. 3-week supplementation of a control supplement on carbohydrate malabsorption (by means of a lactose tolerance test), Bifidobacterium, GI complaints, general well-being and overall gut microbiota in people screened for not reporting substantial GI complaints while being lactose non-persistent (LNP) and/or being responsive to a lactose tolerance test.
Part II investigates the impact of a 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement vs. a control supplement on GI complaints, Bifidobacterium, general well-being, overall gut microbiota, immune markers, gut redox status, and short chain fatty acids in feces in people screened for reporting substantial GI complaints.
Both study parts include multiple standardized exercise tests before and after each supplementation period (Part I: 4 exercise testing days, Part II: 2 exercise testing days). The participants will come in fasted (after not eating starting 10 pm the night before) and they will perform a 60-minute hiking protocol in a warm environment. After the first-time participants will copy their personal exercise protocol during the following session(s). The exercise exists of hiking on a treadmill in a warm environment (30-35°C), while reaching an exercise intensity of 70% of the subject's VO2 max. Which is an intensity in which the subject has an elevated breathing frequency but is still able to talk.
SCREENING After being eligible on paper (based on the results of an online screening questionnaire) people are invited to sign informed consent via REDCap, a secure, web-based application designed for building and managing online surveys and databases for research studies.
For Part I an addition screening step is included to determine eligibility, including a buccal swab to determine lactose non-persistence (to identify the CC gene), as well as a lactose tolerance test (administration of a dose of 25g of lactose mixed into 250mL, with hydrogen breath measurements at 30-, 60- and 90-minutes after lactose consumption). For Part II no additional screening will be performed.
FAMILIARIZATION VISIT Before performing any exercise, body height and weight, as well as waist and hip circumference will be taken by a research team member, and some additional questions will be asked about exercise and diet habits. After this the participant will perform a maximal exercise test, that will be used to determine the exercise intensity during the following exercise sessions. For this purpose, the Balke protocol will be used and VO2 max will be measured. This test includes a treadmill walking/hiking test including progressive stages where the incline increases each minute (by 1%), but the speed remains 3.3mph.
EXERCISE TEST (PART I and PART II) The treadmill will start at 70% of the final incline determined by the max test and participants will start the speed determined by the familiarization test and will be increased as necessary to achieve a heart rate associated with 70% of the VO2max measured during the familiarization visit using a Balke test. Heart rate and speed will be continuously monitored, when speed needs to be adjusted at a later phase during the protocol (because heart rate is not within the targeted HR-range), this will be registered to allow for exact copying the protocol during the next exercise sessions. The exercise will consist of 60 minutes of steady-state exercise. A rating of perceived exertion (RPE) measure via a BORG visual analog scale will be taken every 10-minutes to ensure participants are maintaining a moderate level activity. Only during Part I participants will receive a feeding after the exercise test. Participants will receive at the end of the exercise test 25g lactose mixed into 250mL water, no food will be provided after the heat stress test, but water can be consumed ad libitum.
PART I This part has a randomized controlled cross-over design: Some of the data collection will take place at home (e.g the collection of stool samples, 1-3 minutes per sample, 4-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 4-12 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.
Measurements for different testing days for Part I:
Day ≤0: Screening questionnaire (allowing to select eligible athletes based on the criteria listed in inclusion and exclusion criteria). Sign informed consent, perform exercise test to determine heart rate submax including measuring body composition. Provide instructions and provide stool sample collection materials.
Test Day 0, 21, 42, 63: Fecal swab (for microbiota-redox activity) before arrival; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires at arrival. Blood sample is taken based on a finger prick using a lancet method (for SCFA/LBP) before the exercise test followed by the exercise test, and another finger prick (~150 uL blood for LBP). After the lactose dose is consumed post-exercise, multiple hydrogen breath samples are collected (malabsorption). Hydrogen measurements will be issued at baseline (-60 min), post-exercise (0 min), 30-minutes post-exercise (30 min), 60-minutes post-exercise (60 min), 90-minutes post-exercise (90min), 120-minutes post-exercise (120min) 150-minutes post-exercise (150min), 180-minutes post-exercise (180min), 210-minutes post exercise and 240-minutes post exercise (240min). Hydrogen breath analysis is a minimally invasive procedure which requires the participant to breath normally but exhale into a gas sample bag until the 250mL bag is filled. Prior to taking a hydrogen breath sample, a 10mL mouthwash rinse followed by a rinse with water to prevent bacterial flora from affecting the hydrogen breath measures will be completed before each measure of hydrogen.
Accompanying the hydrogen breath test at 0 min, 60 min, 120 min, 180 min and 240 min, an adjusted GSRS questionnaire will also be given for self-reported digestive comfort during the last 60 minutes.
Test Day 0+1; Day 21+1, Day 42+1, Day 63+1: Before the exercise stress test the regular GSRS will be provided to reflect self-reported digestive comfort during the last week, and a 24-hour after exercise an adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.
Research questions for Part I:
Question 1: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers lactose malabsorption reflected by consecutive hydrogen breath measurements compared to a control after 60-minute hiking exercise in the heat.
Question 2: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.
Question 3: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) during the lactose tolerance test after 60-minute hiking exercise in the heat.
Question 4: For Part I: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota.
PART II This part has a randomized controlled parallel design: Some of the data collection will take place at home (e.g the collection of stool samples, 3-6 minutes for two samples a time, 6-12 minutes total, and filling out a GSRS questionnaire the day after each exercise test for 1-3 minutes per questionnaire, 2-6 minutes total), as well as the consumption of the intervention product or placebo (1-2 minutes per day, 21-42 minutes total), but the majority of the measurements will be collected at our research facility.
Measurements for different testing days for Part II:
Screening (Day ≤0): Screening questionnaire (select eligible athletes based on inclusion and exclusion criteria); Sign informed consent, perform exercise test to determine heart rate submax, including measuring body composition. Provide instructions and provide stool sample collection materials.
Baseline (Day 0) and Endpoint (Day 21): Fecal swab (for microbiota-redox activity, SFCA composition) before arrival; Venous blood sample (5 mL to measure TNF-a, CRP, IL-4, IL-6, IL-8, IL-10, MCP-1) and saliva (check swab to measure sIgA, and assessment of flow rate) collection for immune markers; Self-reported digestive comfort, general wellbeing (PHQ. K6, SVS), and dietary questionnaires filled out online. An additional blood sample is taken based on a finger prick using a lancet method (~250 uL blood to measure SCFA and LBP) before the exercise test followed by the exercise test, and another finger prick (to measure LBP again).
Day 0+1 and Day 21+1: day after exercise stress test: A 24-hour after exercise adjusted GSRS questionnaire will be provided to assess the last 24-h for self-reported digestive comfort.
Research questions for Part II:
Question 5: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement lowers GI complaints based on a modified gastro-intestinal symptom rating scale (GSRS) before, directly after, and 24-hours after 60-minute hiking exercise in the heat compared to a control.
Question 6: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement increase fecal Bifidobacterium compared to a control.
Question 7: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in general wellbeing (measured via multiple questionnaires) and general gut microbiota compared to a control.
Question 8: For Part II: Does 3-week supplementation of a fermented dairy protein with prebiotic fiber supplement result in positive changes in immune markers, gut redox status and fecal short chain fatty acids compared to a control.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- Part I is a crossover design. Part II is a parallel design.
| Arm | Type | Receives |
|---|---|---|
| Fermented dairy protein with prebiotic fiber | Experimental | Dietary Supplement: Fermented dairy protein with prebiotic fiber supplementDuring 3-week period participants consume a fermented dairy protein with prebiotic fiber. During Part I participants are randomly assigned to start with the experimental arm or the control arm, after a 3-week washout period, they will supplement again for 3 weeks with the opposite supplement (double blind, randomized cross-over trial). During Part II participants are randomly assigned to the experimental arm only (double blind, randomized parallel trial). |
| Control protein supplement | Placebo comparator | Dietary Supplement: Control placeboDuring 3-week period participants consume a control supplement. During Part I participants are randomly assigned to start with the control arm or the experimental arm, after a 3-week washout period, they will supplement again for 3 weeks with the opposite supplement (double blind, randomized cross-over trial). During Part II participants are randomly assigned to the control arm only (double blind, randomized parallel trial). |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (11 listed)
- Healthy subjects living in the Phoenix area in AZ, USA during the study
- Women/Men aged between 18-50 years (50-50%)
- Recreational competitive and non-competitive athletes (exercise at least 2x per week with a minimal total duration of 2 hours/week)
- BMI value between ≥18.5 and ≤ 30 kg/m2
- No physical limitations due to an injury (i.e., able to perform all activities associated with daily living and exercise in an independent manner).
Key exclusion criteria (18 listed)
- Users of (sport) supplements containing probiotics and/or prebiotics and those unwilling to temporarily stop use of these supplements at least 3 weeks prior to start of the intervention
- Women who plan to start or stop the use of contraceptives before or during study period
- Women that have additional or worse GI symptoms during their period that can be classified as severe
- Smoking
- Clinical lactose intolerance
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fermented dairy protein with prebiotic fiber supplementBoth the intervention and placebo products contain a serving of 15g with ~53Kcal, 0.5g Fats, 5g Carbohydrate, 7.5g Protein that need to be dissolved as powder in water in a protein shaker that will be provided. The intervention product contains whey protein concentrate and a prebiotic fiber. All ingredients that are designated by the FDA as Generally Recognized as Safe (GRAS). Participants will be asked to take the supplement daily before breakfast. | Dietary supplement | Fermented dairy protein with prebiotic fiber |
| Control placeboBoth the intervention and placebo products contain a serving of 15g with ~53Kcal, 0.5g Fats, 5g Carbohydrate, 7.5g Protein that need to be dissolved as powder in water in a protein shaker that will be provided. The placebo product is calorically matched to the intervention product and the main ingredients are protein and carbohydrate. All ingredients that are designated by the FDA as Generally Recognized as Safe (GRAS). Participants will be asked to take the supplement daily before breakfast. | Dietary supplement | Control protein supplement |
Primary outcome
Part I: Hydrogen in breath
Time frame: For 240 minutes post exercise after consuming a bolus of lactose.
Hydrogen in breath as indicator of lactose malabsorption.
Part II: Gastrointestinal Symptoms Rating Scores
Time frame: For 240 minutes post exercise after consuming a bolus of lactose.
Gastrointestinal Symptoms Rating Scores (GSRS) as indicator of self-reported digestive comfort. The GSRS is a 15-item self-administered questionnaire divided into five clusters of symptoms: reflux, abdominal pain, indigestion, diarrhea, and constipation. These symptoms are graded on a 7-point Likert scale, where 1 signifies no discomfort at all and 7 represents very severe discomfort. The total score will be calculated, as well as the percentage of subjects reporting symptoms (≥2), or moderate to severe symptoms (≥4). A minimal score of indicates no GI symptoms, whereas a score up to 105 suggests extreme GI symptoms.
1 secondary outcome
Part I and Part II: Fecal Bifidobacterium
Time frame: Stool sample collected at least one day before the test day including the exercise test
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- Background: PubMed 38892645Wardenaar FC, Mohr AE, Ortega-Santos CP, Nyakayiru J, Kersch-Counet C, Chan Y, Clear AM, Kurka J, Schott KD, Seltzer RGN. Explorative Characterization of GI Complaints, General Physical and Mental Wellbeing, and Gut Microbiota in Trained Recreative and Competitive Athletes with or without Self-Reported Gastrointestinal Symptoms. Nutrients. 2024 May 30;16(11):1712. doi: 10.3390/nu16111712.
- Individual participant dataSharing planned: No. This is up to the industry funder to allow sharing.
Related trials for Digestive Health
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
Recruiting
NAFLD Clinical Care Pathway
NAFLD, MASLD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kinta Schott, MS contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fermented dairy protein with prebiotic fiber supplement in people with Digestive Health and Quality of Life, run by Arizona State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Floris C Wardenaar, PhD (602-543-1853, Floris.wardenaar@asu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Part I: Hydrogen in breath (time frame: For 240 minutes post exercise after consuming a bolus of lactose.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06946017, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.